File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Targeted protein delivery based on stimuli‐triggered nanomedicine

TitleTargeted protein delivery based on stimuli‐triggered nanomedicine
Authors
Issue Date23-Nov-2023
PublisherWiley Open Access
Citation
Exploration, 2023 How to Cite?
Abstract

Protein-based drugs have shown unique advantages to treat various diseases in recent years. However, most protein therapeutics in clinical use are limited to extracellular targets with low delivery efficiency. To realize targeted protein delivery, a series of stimuli-triggered nanoparticle formulations have been developed to improve delivery efficiency and reduce off-target release. These smart nanoparticles are designed to release cargo proteins in response to either internal or external stimuli at pathological tissues. In this way, varieties of protein-based drugs including antibodies, enzymes, and pro-apoptotic proteins can be effectively delivered to desired sites for the treatment of cancer, inflammation, metabolic diseases, and so on with minimal side effects. In this review, recent advances in the design of stimuli-triggered nanomedicine for targeted protein delivery in different biomedical applications will be discussed. A deeper understanding of these emerging strategies helps develop more efficient protein delivery systems for clinical use in the future.


Persistent Identifierhttp://hdl.handle.net/10722/339317
ISSN

 

DC FieldValueLanguage
dc.contributor.authorLiu, Jinzhao-
dc.contributor.authorZhou, Yang-
dc.contributor.authorLyu, Qingyang-
dc.contributor.authorYao, Xiaotong-
dc.contributor.authorWang, Weiping-
dc.date.accessioned2024-03-11T10:35:39Z-
dc.date.available2024-03-11T10:35:39Z-
dc.date.issued2023-11-23-
dc.identifier.citationExploration, 2023-
dc.identifier.issn2766-2098-
dc.identifier.urihttp://hdl.handle.net/10722/339317-
dc.description.abstract<p>Protein-based drugs have shown unique advantages to treat various diseases in recent years. However, most protein therapeutics in clinical use are limited to extracellular targets with low delivery efficiency. To realize targeted protein delivery, a series of stimuli-triggered nanoparticle formulations have been developed to improve delivery efficiency and reduce off-target release. These smart nanoparticles are designed to release cargo proteins in response to either internal or external stimuli at pathological tissues. In this way, varieties of protein-based drugs including antibodies, enzymes, and pro-apoptotic proteins can be effectively delivered to desired sites for the treatment of cancer, inflammation, metabolic diseases, and so on with minimal side effects. In this review, recent advances in the design of stimuli-triggered nanomedicine for targeted protein delivery in different biomedical applications will be discussed. A deeper understanding of these emerging strategies helps develop more efficient protein delivery systems for clinical use in the future.<br></p>-
dc.languageeng-
dc.publisherWiley Open Access-
dc.relation.ispartofExploration-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleTargeted protein delivery based on stimuli‐triggered nanomedicine-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1002/EXP.20230025-
dc.identifier.eissn2766-2098-
dc.identifier.issnl2766-2098-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats